Guardian Pharmacy Services, Inc. Class A (GRDN)
NYSE:GRDN
Want to see GRDN full AI Analyst Report?
GRDN Stock Chart & Stats
$37.54
$0.47(2.39%)
At close: 4:00 PM EST
$37.54
$0.47(2.39%)
Day’s Range― - ―
52-Week Range$19.17 - $41.36
Previous Close$20.98
Volume93.63K
Average Volume (3M)348.83K
Market Cap
$2.27B
Enterprise Value$2.35B
Total Cash (Recent Filing)$64.89M
Total Debt (Recent Filing)$36.88M
Price to Earnings (P/E)44.8
Beta0.56
Next Earnings
Aug 17, 2026EPS Estimate
0.26Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.85
Shares Outstanding49,781,180
10 Day Avg. Volume450,542
30 Day Avg. Volume348,833
Financial Highlights & Ratios
PEG Ratio-0.26
Price to Book (P/B)9.12
Price to Sales (P/S)1.30
P/FCF Ratio23.26
Enterprise Value/Market Cap1.04
Enterprise Value/Revenue1.62
Enterprise Value/Gross Profit7.73
Enterprise Value/Ebitda23.19
Forecast
1Y Price Target
$43.00Price Target Upside14.54% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)1.23
Revenue Forecast (FY)$1.41B
Bulls Say, Bears Say
Bulls Say
Very Low Leverage / Stronger Balance SheetDebt-to-equity falling to ~0.03x TTM and equity expansion create durable financial flexibility. Low leverage reduces refinancing and solvency risk, supports M&A/greenfield spending, and provides a buffer against reimbursement or working-capital shocks over the next several quarters.
Accelerating Revenue And Profitability ReboundSustained revenue acceleration to ~50% TTM coupled with a return to positive earnings signals durable demand and improved unit economics. This top-line strength underpins capacity to expand margins, invest in scale, and generate recurring cash flow across the 2–6 month horizon.
Operational Resilience And Scale Under IRAThe company completed its first full quarter under the IRA framework while growing residents and scripts ~10% y/y, showing operational execution, payor negotiation ability, and scale advantages. These capabilities improve long-term resilience to regulatory change.
Bears Say
Thin And Volatile MarginsLow TTM net and EBITDA margins leave earnings and cash flow vulnerable to modest cost increases or reimbursement changes. Historical swings (loss in 2024 then rebound) indicate persistent profitability volatility that could constrain sustained margin expansion.
Severe IRA-driven Branded Pricing DeclineA ~60% branded pricing drop from the IRA is a structural regulatory shock that materially reduces revenue realization and gross margin. Ongoing policy uncertainty forces repeated payor negotiations and creates a durable headwind to profitability and pricing power.
Acquisition Integration Drag On MarginsRecent M&A is dilutive to consolidated margins (~80bps drag) and management anticipates continued integration-related pressure through 2026–2027. Persistent acquisition drag increases earnings volatility and slows margin recovery even as revenue scales.
Guardian Pharmacy Services, Inc. Class A News
GRDN FAQ
What was Guardian Pharmacy Services, Inc. Class A’s price range in the past 12 months?
Guardian Pharmacy Services, Inc. Class A lowest stock price was $19.17 and its highest was $41.36 in the past 12 months.
What is Guardian Pharmacy Services, Inc. Class A’s market cap?
Guardian Pharmacy Services, Inc. Class A’s market cap is $2.27B.
When is Guardian Pharmacy Services, Inc. Class A’s upcoming earnings report date?
Guardian Pharmacy Services, Inc. Class A’s upcoming earnings report date is Aug 17, 2026 which is in 88 days.
How were Guardian Pharmacy Services, Inc. Class A’s earnings last quarter?
Guardian Pharmacy Services, Inc. Class A released its earnings results on May 06, 2026. The company reported $0.29 earnings per share for the quarter, beating the consensus estimate of $0.24 by $0.05.
Is Guardian Pharmacy Services, Inc. Class A overvalued?
According to Wall Street analysts Guardian Pharmacy Services, Inc. Class A’s price is currently Undervalued.
Does Guardian Pharmacy Services, Inc. Class A pay dividends?
Guardian Pharmacy Services, Inc. Class A does not currently pay dividends.
What is Guardian Pharmacy Services, Inc. Class A’s EPS estimate?
Guardian Pharmacy Services, Inc. Class A’s EPS estimate is 0.26.
How many shares outstanding does Guardian Pharmacy Services, Inc. Class A have?
Guardian Pharmacy Services, Inc. Class A has 49,781,180 shares outstanding.
What happened to Guardian Pharmacy Services, Inc. Class A’s price movement after its last earnings report?
Guardian Pharmacy Services, Inc. Class A reported an EPS of $0.29 in its last earnings report, beating expectations of $0.24. Following the earnings report the stock price went down -0.847%.
Which hedge fund is a major shareholder of Guardian Pharmacy Services, Inc. Class A?
Currently, no hedge funds are holding shares in GRDN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Guardian Pharmacy Services, Inc. Class A Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$43.00 (14.54% Upside)
$43.00 (14.54% Upside)
Hedge Fund Trend
Decreased
By 81.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $419.2M over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
28.50%
12-Months-Change
Fundamentals
Return on Equity
27.21%
Trailing 12-Months
Asset Growth
27.83%
Trailing 12-Months
Company Description
Guardian Pharmacy Services, Inc. Class A
Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company's Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs. The company was founded in 2003 and is based in Atlanta, Georgia.
GRDN Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed a positive operational and financial outturn for Q1 2026: the company successfully navigated major IRA-driven disruption, delivered revenue resilience, strong gross profit and adjusted EBITDA growth, and raised adjusted EBITDA guidance. Key risks remain, including a severe (~60%) branded pricing decline caused by the IRA, temporary working capital and payment-timing stresses, margin pressure from recent acquisitions (~80 bps drag), and potential cost headwinds from fuel and labor. Management emphasized scale advantages, proactive payor negotiations, and confidence in normalization of working capital, while noting that certain quarter-specific benefits are non-recurring. On balance, highlights demonstrating execution and financial strength outweigh the lowlights tied mainly to one-time disruptions and ongoing cost/legislative uncertainty.View all GRDN earnings summariesGRDN Stock 12 Month Forecast
Average Price Target
$43.00
▲(14.54% Upside)
Technical Analysis
Ownership Overview
Currently, No data available
---